Every article, presentation, spotlight, and news item we've tagged to Hallmarks of Aging.
Showing 1–24 of 225
A Cell Genomics study demonstrates that age-related systemic inflammation (inflammaging) correlates with epigenetic aging as measured by established epigenetic clocks. This connection bridges two major aging hallmarks and suggests chronic low-grade immune activation reflects measurable changes in gene expression patterns independent of overt disease.
Intestinal aging creates a self-reinforcing cycle where the gut barrier weakens, immune function declines, and harmful bacteria replace beneficial species. This shift compromises the production of short-chain fatty acids and other metabolites that support immune regulation, accelerating mucosal dysfunction and systemic inflammation with advancing age.
Circulating stem cell count declines sharply after age 30, reducing tissue repair capacity and resilience. This decline correlates with recovery time, injury healing, and disease risk—making stem cell abundance a measurable predictor of healthspan independent of conventional longevity markers.
Aging disrupts intestinal mucosal immunity through a cascade of changes: epithelial barrier weakening, shifts toward pro-inflammatory gut bacteria, dysregulation of immune surveillance cells, and impaired pathogen recognition. This multi-system breakdown creates a mechanistic link between microbial composition and immune dysfunction that directly drives infection susceptibility in older adults.
Advanced glycation end products accumulate in cardiac mitochondria with age, impairing lysosomal function and mitochondrial quality control. This impaired clearance mechanism drives cellular senescence and represents a mechanistic link between cardiac aging and heart failure development.
Protein misfolding drives over 100 diseases and accelerates aging-related decline. Origami Therapeutics is developing targeted protein degraders and conformation correctors that address root cause mechanisms rather than symptoms, with initial focus on neurodegenerative diseases including Huntington's, Alzheimer's, and Parkinson's.
Impaired neuronal autophagy precedes amyloid-beta and tau pathology in Alzheimer's disease, suggesting that restoring cellular clearance mechanisms may address disease onset at a mechanistic level upstream of classical biomarkers. This positions autophagy dysfunction as a tractable target for intervention before irreversible neurodegeneration.
Urban environments in sub-Saharan Africa show accelerated inflammaging—chronic, low-grade systemic inflammation associated with aging—driven by environmental stressors including air pollution, pathogenic load, and dietary shifts. This research identifies modifiable environmental and lifestyle factors that influence the rate of immunological aging independent of chronological age.
The NUS Academy for Healthy Longevity is hosting a Geromedicine Conference in February 2026 to advance the clinical translation of geroscience research into practical interventions. The event will focus on implementing evidence-based strategies including targeted molecules, bioactive compounds, and repurposed pharmaceuticals within personalized care frameworks.
Wound healing in young skin relies on a coordinated senescence response in fibroblasts that produces tissue-remodeling proteins and supports closure. In aged individuals, this response is both diminished and functionally altered toward inflammation, directly impairing repair capacity and contributing to delayed healing.
Single-cell immune profiling distinguishes centenarians from age-matched controls through divergent intercellular communication patterns: healthy aging shows reinforced regulatory signaling supporting cytotoxicity and immune surveillance, while standard aging exhibits self-amplifying senescence signals linked to immune exhaustion. This immune remodeling signature may explain exceptional longevity phenotypes.
Aging impairs the rapid recruitment and metabolic function of neutrophils during pneumonia, a decline driven by chronic inflammation and cellular senescence that can be partially reversed by blocking TNFα. This mechanism explains age-related vulnerability to infection and identifies a potential intervention point.
Research published in PNAS Nexus proposes that autophagy dysfunction—a slowdown in cellular recycling—precedes amyloid and tau pathology in Alzheimer's disease. This upstream mechanism shifts the therapeutic target from clearing late-stage debris to restoring the cell's natural cleanup capacity earlier in disease progression.
Aging drives a senescent-like state in neutrophils characterized by impaired energy metabolism and excessive inflammatory signaling, reducing their capacity to kill respiratory pathogens. Blocking TNFα restores antimicrobial function and improves infection resistance in aged hosts, identifying a tractable mechanism underlying age-related immunocompromise.
Sugar disrupts skin cells at the functional level, pushing them into senescence and chronic inflammation rather than simply damaging collagen structure. This cellular dysfunction mirrors aging patterns throughout the body, positioning dietary sugar management as foundational to longevity rather than cosmetic skin care.
This April 2026 roundup surveys emerging research across multiple aging pathways: metabolic dysfunction accelerates aging in sedentary populations, enzymatic depletion drives cellular senescence in fat tissue, meal timing influences biological aging rates, and targeted interventions—from NAD+ restoration to immune mobilization via sauna—show measurable effects on muscle, cognition, and immune function in animal models.
Aging T cells develop senescence characteristics that drive chronic inflammatory skin diseases through dysregulated signaling pathways and secretion of pro-inflammatory factors. Targeting senescent T cells or their signaling cascades offers a mechanism-based approach to achieving sustained remission in conditions like psoriasis and atopic dermatitis.
Age-related hypermethylation of IGF2BP3 impairs glutathione metabolism in aging stem cells, causing loss of proliferative capacity and regenerative function. This metabolic collapse explains why autologous stem cell therapies perform poorly in older patients and identifies a specific epigenetic mechanism linking aging to cellular dysfunction.
Parasitic infection accelerates oxidative stress and aging markers in host organisms, providing empirical support for redox-based aging mechanisms. This finding illuminates how chronic pathogenic burden compounds systemic dysfunction and accelerates cellular deterioration through reactive oxygen species accumulation.
Proteostasis decline, not telomere dysfunction, emerges as the primary driver of cellular senescence in the respiratory epithelium during normal aging. This distinction has implications for understanding age-related respiratory decline and identifying intervention targets earlier than currently recognized.
Gut microbial metabolites drive systemic aging through a conserved signature of depleted protective compounds (lysophosphatidylcholines) and accumulated pro-oxidative catabolites (TMAO, indole-3-acetic acid), which propagate redox stress across liver, lung, and brain. Microbiome interventions that restore this metabolic balance reverse key aging phenotypes and enhance antioxidant capacity, establishing the gut-metabolite axis as a modifiable target for extending healthspan.
Mesenchymal stem cells in bone marrow show contradictory roles in aging—they support bone regeneration but accumulate as fat cells that displace bone-forming capacity. This duality reveals why bone density declines despite maintained stem cell populations, a critical mechanism in skeletal aging.
The heart undergoes progressive cellular dysfunction with age, driven by mitochondrial impairment, cellular senescence, and fibrosis, with heart failure prevalence increasing from 1% in those under 55 to over 10% in those over 70. Understanding these mechanisms is essential for developing targeted interventions against age-related cardiac disease.
Advanced glycation end products suppress SIRT1 expression in osteoclasts, triggering RANKL-dependent bone resorption and accelerated chondrocyte senescence—a mechanism that directly couples metabolic stress to cartilage degradation in osteoarthritis. This pathway represents a biochemical link between systemic glucose metabolism and joint degeneration, suggesting that metabolic control earlier in life may alter osteoarthritis trajectory.
